Holly A. Swartz, MD

a:1:{i:0;s:95:"Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania";}

JCP
What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon?
ASCP Corner

June 2, 2025

The authors encourage the field to destigmatize the term “deprescribing” from its misappropriated usage, explicate its accurate definition, and reclaim its purposeful meaning.
, , , et al
JCP
Addressing Unmet Needs in Bipolar Disorder
Academic Highlights

November 16, 2022

Bipolar disorder presents on a spectrum, with bipolar depression on one end and bipolar I on the other and a host of other presentations in between. As guidelines are...
, ,
JCP
Original Research

July 11, 2017

Quetiapine has the greatest evidence of efficacy for bipolar II depression, but it is also associated with metabolic side effects. This study compared psychotherapy plus placebo or plus pharmacotherapy....
, , , et al
JCP
ASCP Corner

December 15, 2012

,
JCP
Original Research

August 10, 2010

,
JCP
Article

August 31, 2008

, , , et al
JCP
Educational Activity

May 11, 2008

JCP
Original Research

June 18, 2002

, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe